Back
Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
SNDX
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
19
SNDX
Syndax Pharmaceuticals
Last Price:
19.00
Seasonality Move:
12.37%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.Syndax Pharmaceuticals Price Quote
$19.00
+0.46 (+2.48%)
(Updated: October 24, 2024 at 4:00 PM ET)
Syndax Pharmaceuticals Key Stats
Sell
19
Syndax Pharmaceuticals (SNDX)
is a Sell
Day range:
$18.51 - $19.30
52-week range:
$11.50 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.75%
Volume:
592.4K
Avg. volume:
919.6K
1-year change:
62.77%
Market cap:
$1.6B
Revenue:
$0
EPS:
$-3.38
How Much Does Syndax Pharmaceuticals Make?
Data Unavailable
Is Syndax Pharmaceuticals Growing As A Company?
Data Unavailable
Syndax Pharmaceuticals Stock Price Performance
-
Did Syndax Pharmaceuticals Stock Go Up Last Month?
Syndax Pharmaceuticals share price went up by 3.4% last month -
Did SNDX's Share Price Rise Over The Last Year?
SNDX share price rose by 62.77% over the past 1 year
What Is Syndax Pharmaceuticals 52-Week High & Low?
-
What Is Syndax Pharmaceuticals’s 52-Week High Share Price?
Syndax Pharmaceuticals has traded as high as $25.34 over the past 52 weeks -
What Is Syndax Pharmaceuticals’s 52-Week Low Share Price?
Syndax Pharmaceuticals has traded as low as $11.50 over the past 52 weeks
Syndax Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Syndax Pharmaceuticals?
-
How Much Debt Does Syndax Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Syndax Pharmaceuticals Have?
Cash and short term investments quarterly total is $432.3M -
What Is Syndax Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.11
Is Syndax Pharmaceuticals Cash Flow Positive?
-
What Is SNDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$241.2M -
What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $263.2M -
What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$13.9M
Syndax Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SNDX return on invested capital is -58.96% -
What Is Syndax Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -53.6% -
What Is SNDX Return On Equity?
ROE is a measure of profitability and is -58.96%
Syndax Pharmaceuticals Earnings Date & Stock Price
-
What Is Syndax Pharmaceuticals's Stock Price Today?
A single share of SNDX can be purchased today for 18.54 -
What Is Syndax Pharmaceuticals’s Stock Symbol?
Syndax Pharmaceuticals trades on the nasdaq under the ticker symbol: SNDX -
When Is Syndax Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Syndax Pharmaceuticals is scheduled on November 1, 2024 -
When Is SNDX's next ex-dividend date?
Syndax Pharmaceuticals's next ex-dividend date is October 24, 2024 -
How To Buy Syndax Pharmaceuticals Stock?
You can buy Syndax Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Syndax Pharmaceuticals Competitors
-
Who Are Syndax Pharmaceuticals's Competitors?
Below is a list of companies who compete with Syndax Pharmaceuticals or are related in some way:
Syndax Pharmaceuticals Dividend Yield
-
What Is SNDX Dividend Yield?
Syndax Pharmaceuticals’s dividend yield currently is 0% -
What Is Syndax Pharmaceuticals’s Payout Ratio?
Syndax Pharmaceuticals’s payout ratio is 0% -
When Did Syndax Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 24, 2024 -
What Is Syndax Pharmaceuticals’s Dividend Per Share?
Syndax Pharmaceuticals pays a dividend of $0.00 per share
Syndax Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 12.17% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 35.23 |
Upside from Last Price: | 90.03% |